)
)
Mind the Implementation Gap: What If Every Older Adult Had Their Pharmacogenomic Profile on File?
-
Presents real-world evidence and experience from Scotland to explore how pharmacogenomics can optimise prescribing in older adults.
-
Highlights equity challenges, multimorbidity, and polypharmacy as key drivers of missed opportunities for pharmacogenomic-guided care in the NHS.
-
Explores common barriers to PGx adoption head-on: feasibility, acceptability, and affordability — with evidence-based responses from trials, population data, and economic modelling.
-
Asks the urgent question: If we already have the tools and evidence, what is holding back PGx implementation at scale?
